Evidence map›Paper›PMID 24443158›Full record

ArticleHuman brain mapping2014

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.

Andreas Hahn, Daniela Haeusler, Christoph Kraus, Anna S Höflich, Georg S Kranz, Pia Baldinger, Markus Savli, Markus Mitterhauser, Wolfgang Wadsak, Georgios Karanikas and 2 more

Abstract read
In one paragraph

Article in Human brain mapping, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Meta-analysis of molecular imaging of serotonin transporters in major depression.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular connectivity studies in neurotransmission: a scoping review.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  11. Feasibility of Using Serum, Plasma, and Platelet 5-hydroxytryptamine as Peripheral Biomarker for the Depression Diagnosis and Response Evaluation to Antidepressants: Animal Experimental Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  12. Effects of the suppression of 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. The role of microglia in neuropsychiatric disorders and suicide.European archives of psychiatry and clinical neuroscience · 2022
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andreas HahnDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Austria.
Daniela Haeusler
Christoph Kraus
Anna S Höflich
Georg S Kranz
Pia Baldinger
Markus Savli
Markus Mitterhauser
Wolfgang Wadsak
Georgios Karanikas
Siegfried Kasper
Rupert Lanzenberger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suffering from anhedonia, patients with major depressive disorder (MDD) exhibit alterations in several parts of the serotonergic neurotransmitter system, which are in turn involved in reward processing. However, previous investigations of the serotonin transporter (SERT) focused on regional differences with varying results depending on the clinical syndrome. Here, we aimed to describe the serotonergic system of MDD patients on a network level by evaluating SERT associations across brain regions. Twenty medication free patients with major depression and 20 healthy controls underwent positron emission tomography using the radioligand [(11) C]DASB. SERT binding potentials (BPND ) were quantified voxel-wise with the multilinear reference tissue model 2. In addition, SERT BPND was extracted from the dorsal raphe nucleus (DRN) as an indicator of midbrain serotonergic neurotransmission. Whole-brain linear regression analysis was applied to evaluate the association of DRN SERT bindings to those in projection areas, which was followed by ANCOVA to assess differences in interregional relationships between patients and controls. Although both groups showed widespread positive correlations, group differences were restricted to decreased SERT associations between the DRN and the ventral striatum (right and left respectively: t=5.85, P<0.05 corrected and t=5.07, P<0.1 corrected) when comparing MDD patients (R(2)=0.11 and 0.24) to healthy subjects (R(2)=0.72 and 0.66, P<0.01 and 0.05 corrected). Adjusting for age and sex did not change these findings. This study indicates a disturbed regulation between key regions involved in reward processing via the SERT. Our interregional approach highlights the importance of evaluating pathophysiological alterations on a network level to gain complementary information in addition to regional investigations.

Indexed as

AdultBenzylaminesBrainBrain MappingCarbon RadioisotopesDorsal Raphe NucleusFemaleHumansMajor Depressive DisorderMalePositron-Emission TomographyRadiopharmaceuticalsRegression AnalysisSerotonin Plasma Membrane Transport ProteinsSignal Processing, Computer-AssistedSmokingBenzylaminesCarbon RadioisotopesN,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamineRadiopharmaceuticalsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, humandorsal raphe nucleusinterregional associationmajor depressionpositron emission tomographyserotonin transporterventral striatum

Identifiers

PMID24443158
PMCPMC6868983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.